GLP-1 medications are known to suppress thirst in addition to appetite
This is exactly why the review process exists: to help ensure that decisions are based on evidence, viability, and clinical need, rather than demand or trend
CrossRef Cholinesterase and the association between hepatic steatosis and liver fibrosis in patients with prior hepatitis E Ziteng Wang, Zhe Yu, Wen An, Herui Wei, Jing Luo, Mengqi Li, Lingling He, Jiali Ma, Fan Xiao, Lijuan Sun, Qi Gao, Hui Zhong, Hongshan Wei European Journal of Medical Research .2026;[Epub] CrossRef Hepatitis E Virus Infection as a Trigger of Hepatic Decompensation: A SingleCenter Prospective and CrossSectional Study From Rosario, Argentina Julin Acosta, Alceo Galimberti, Fernando Bessone, Hugo Tanno, Daniela Gardiol, Mara Virginia Reggiardo, Ana Laura Cavatorta Journal of Medical Virology .2026;[Epub] CrossRef Nationwide Detection and Molecular Characterization of Hepatitis E Virus RNA in Retail Pork Meat in Japan Masaharu Takahashi, Manri Kawakami, Yukihiro Sato, Tatsunori Nakano, Jun Inoue, Junichi Koyama, Hitoshi Mizuo, Tomoya Koda, Kazumi Yamasaki, Hiroshi Okano, Akio Miyasaka, Shunji Watanabe, Norio Isoda, Tomofumi Takagi, Shinji Fujiwara, Hiroshi Ohnishi, Put Viruses .2026
GLP-1 is a drug to promote weight loss in people who are considered obese and/or overweight
